Inhaled β2-Agonist Therapy Increases Functional Residual Capacity in Mechanically Ventilated Children With Respiratory Failure.

@article{Ramsi2015InhaledT,
  title={Inhaled β2-Agonist Therapy Increases Functional Residual Capacity in Mechanically Ventilated Children With Respiratory Failure.},
  author={Musaab A Ramsi and Michael Norman Henry and Carlos E Milla and David N. Cornfield},
  journal={Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies},
  year={2015},
  volume={16 7},
  pages={e189-93}
}
OBJECTIVES To test the hypothesis that in mechanically ventilated children with respiratory failure, aerosolized albuterol modifies functional residual capacity, lung mechanics, oxygen consumption, and hemodynamics. DESIGN Prospective, self-control clinical trial. SETTING A 24-bed PICU in a quaternary care, academic children's hospital. PATIENTS 25 children (age range, 1-18 yr) undergoing mechanical ventilation to treat respiratory failure. Entry criteria included previously prescribed… CONTINUE READING